Evaluating Characteristics Of Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment: Budesonide/formoterol Combination (bfc) Versus Tiotropium

被引:0
|
作者
Williams, S. [1 ]
Trudo, F. [1 ]
Kern, D. [2 ]
Wessman, C. [1 ]
Tunceli, O. [2 ]
Zhou, S. [2 ]
Pethick, N. [1 ]
Elhefni, H. [1 ]
机构
[1] Astra Zeneca LP, Wilmington, DE USA
[2] HealthCore Inc, Wilmington, DE USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4378
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Comparative Effectiveness Of Budesonide/formoterol Combination (bfc) And Tiotropium Bromide Among Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment
    Strange, C. B.
    Racketa, J.
    Kern, D. M.
    Williams, S. A.
    Tunceli, O.
    Zhou, S.
    Graham, E.
    Trudo, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [2] Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease
    Feng, Jun-fei
    Ding, Guo-rong
    Xie, Yan-zhong
    Zhao, Dejun
    Wang, Xuehui
    MEDICINE, 2018, 97 (22)
  • [3] The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease
    Um, Sang-Won
    Yoo, Chul-Gyu
    Kim, Young Whan
    Han, Sung Koo
    Shim, Young-Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (05) : 839 - 845
  • [4] Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease
    Centanni, S
    Di Marco, F
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (14) : 2525 - 2534
  • [5] Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
    Welte, Tobias
    Miravitlles, Marc
    Hernandez, Paul
    Eriksson, Goran
    Peterson, Stefan
    Polanowski, Tomasz
    Kessler, Romain
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (08) : 741 - 750
  • [6] Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
    Trudo, Frank
    Kern, David M.
    Davis, Jill R.
    Tunceli, Ozgur
    Zhou, Siting
    Graham, Emma L.
    Strange, Charlie
    Williams, Setareh A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2055 - 2066
  • [7] Erratum to: Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease
    Nicole Mittmann
    Paul Hernandez
    Carl Mellström
    Lance Brannman
    Tobias Welte
    PharmacoEconomics, 2011, 29 : 414 - 414
  • [8] Effect of Triple Therapy with Budesonide-Formoterol-Tiotropium Versus Placebo-Tiotropium on Sleep Quality in Patients with Chronic Obstructive Pulmonary Disease
    Krachman, Samuel L.
    Vega, Maria Elena
    Yu, Daohai
    Demidovich, Joseph
    Patel, Harsh
    Jaffe, Frederic
    Soler, Xavier
    Shariff, Tahseen
    D'Alonzo, Gilbert E.
    Chatila, Wissam
    Weaver, Sheila
    Daraz, Yasmin
    Cohen, Sydney
    Criner, Gerard J.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (02): : 219 - 229
  • [9] Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
    Jayanthi, Nalini
    Krishnan, Karthickeyan
    Sudhir, Manali
    Girija, S.
    Nishi, P. A.
    Kumar, J. Sathish
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 28
  • [10] Budesonide/formoterol in chronic obstructive pulmonary disease
    Reynolds, NA
    Perry, CM
    Keating, GM
    DRUGS, 2004, 64 (04) : 431 - 441